Aitia
Aitia uses AI and digital twins to discover breakthrough drugs.
Free5.0
What is Aitia?
Aitia is a biotech company that harnesses Causal AI, Multi-Omics data, and Gemini Digital Twins to discover the next generation of breakthrough drugs. Their mission is to build the leading AI-enabled biotech company that accelerates the discovery and development of life-saving therapeutics to make a meaningful impact on the lives of patients. Aitia reveals the hidden biological mechanisms of disease with the power of causal AI, multi-omic patient data, and their resulting Gemini Digital Twins.
Key features
- Innovative approach to drug discovery using AI and digital twins
- Limited information available on specific drug candidates in the pipeline
- Focus on addressing unmet needs in oncology and neurodegenerative diseases
- The website primarily focuses on the company's technology and approach rather than detailed product information.
- Strong team of AI pioneers, R&D veterans, and biotech company builders
- Strategic partnerships with industry-leading companies